Oman Economic Relief: Oman announced facilitative measures to cushion geopolitical shocks, including stabilising electricity tariffs for food-security sites at 12 baisas/kWh until Dec 2026, support for maritime transport of food imports for six months, fixed 5% customs on rebar until year-end, and a three-month postponement of a 4% tourism levy for affected hospitality firms. Maritime Safety & Health Impact: As the Strait of Hormuz remains a flashpoint, shipping disruptions and attacks have raised urgent health and welfare concerns for seafarers; Oman’s role in rescues continues to matter for medical evacuation and continuity of care. Royal Hospital Accreditations: Royal Hospital in Muscat secured two international accreditations—WAO Centre of Excellence for immunology/allergy care and GA²LEN ADCARE for atopic dermatitis—highlighting stronger standards for diagnosis and treatment. Child Protection Coordination: Oman’s Child Protection Committee met to unify child protection mechanisms across governorates, strengthen awareness, and improve early detection and electronic case-management links, including education and health support for children in public care. OPAZ Specialised Industries: OPAZ is pushing distinct industrial identities for Oman’s zones, with Salalah focusing on pharma/medical and food security industries, and Duqm advancing green economy and sustainable manufacturing. Environment & Public Health: The plastic bag ban enters its fifth phase from July 1, expanding restrictions to more commercial activities to reduce pollution risks to land and sea ecosystems. Pharma Deal: Dimerix signed an Asian licensing agreement for its phase III kidney drug DMX-200, potentially expanding access to treatment for rare progressive kidney disease across key markets.